For: | Li YQ, Xin L, Zhao YC, Li SQ, Li YN. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World J Hepatol 2023; 15(6): 786-796 [PMID: PMC10308292 DOI: 10.4254/wjh.v15.i6.786] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v15/i6/786.htm |
Number | Citing Articles |
1 |
Chan Chen, Yifei Lin, Jinni Xu, Qingquan Chen, Jing Huang. Causal relationship between green tea intake and gastrointestinal disorders: a two-sample Mendelian randomization study. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1426779
|
2 |
Carlos Rojano-Alfonso, Marc Micó-Carnero, Cristina Maroto-Serrat, Araní Casillas-Ramírez, Carmen Peralta. Role of VEGFA in type 2 diabetes mellitus rats subjected to partial hepatectomy. npj Gut and Liver 2024; 1(1) doi: 10.1038/s44355-024-00013-9
|
3 |
Milena Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera Stanojlović, Dušan Mladenović. Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison. International Journal of Molecular Sciences 2024; 25(13): 7405 doi: 10.3390/ijms25137405
|
4 |
Zhang Qi, Wang Yan, Xiong Qingfang, Yu Lei, Cao Jieqing, Zhao Chengjun, Yang Yongfeng, Jia Shiliang. Liquiritin Ameliorates Palmitic Acid‐Induced Hepatic Steatosis in Mouse Primary Hepatocytes by Suppressing the VEGFA Signaling Pathway. Journal of Food Biochemistry 2025; 2025(1) doi: 10.1155/jfbc/5387785
|
5 |
Yuqi Li, Wenhao Li, Xiaonan Zhu, Nuo Xu, Qinyu Meng, Wenguo Jiang, Lei Zhang, Meizi Yang, Fang Xu, Yana Li. VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05621-w
|